CEPHAGENIX
Updated 332 days ago
- Age: 3 years
- ID: 44124401/28
Smedeland 26B 2600 Glostrup Denmark
Cephagenix was founded in February 2020, with the aim of identifying and developing new effective migraine treatments...
Cephagenix aims to develop first-in-class KATP channel inhibitors as an efficacious and safe treatment of migraine.